Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether cyclic oral methylprednisolone once every
month has an effect on the intrathecal inflammation in patients suffering from progressive
multiple sclerosis.